These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9117808)

  • 1. Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
    Hall PD; Yui D; Lyons S; Bosso JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):185-9. PubMed ID: 9117808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
    Bigley FP; Forsyth RJ; Henley MW
    Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
    Elmore RL; Contois ME; Kelly J; Noe A; Poirier A
    Clin Ther; 1996; 18(2):246-55. PubMed ID: 8733985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of ciprofloxacin injection with selected drugs and solutions.
    Goodwin SD; Nix DE; Heyd A; Wilton JH
    Am J Hosp Pharm; 1991 Oct; 48(10):2166-71. PubMed ID: 1781473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
    Allen LV; Stiles ML; Prince SJ; Sylvestri MF
    Am J Health Syst Pharm; 1995 Nov; 52(21):2427-33. PubMed ID: 8564608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
    Dotson B; Lynn S; Savakis K; Churchwell MD
    Am J Health Syst Pharm; 2010 Jul; 67(14):1195-8. PubMed ID: 20592327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility and stability of clindamycin phosphate-aminoglycoside combinations within polypropylene syringes.
    Zbrozek AS; Marble DA; Bosso JA; Bair JN; Townsend RJ
    Drug Intell Clin Pharm; 1987 Oct; 21(10):806-10. PubMed ID: 3428140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
    Marble DA; Bosso JA; Townsend RJ
    Drug Intell Clin Pharm; 1986 Dec; 20(12):960-3. PubMed ID: 3816545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefoxitin sodium compatibility with intravenous infusions and additives.
    O'Brien MJ; Portnoff JB; Cohen EM
    Am J Hosp Pharm; 1979 Jan; 36(1):33-8. PubMed ID: 31790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of imipenem and cilastatin sodium in total parenteral nutrient solution.
    Zaccardelli DS; Krcmarik CS; Wolk R; Khalidi N
    JPEN J Parenter Enteral Nutr; 1990; 14(3):306-9. PubMed ID: 2112647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
    So W; Kim L; Thabit AK; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of in vitro inactivation of tobramycin by imipenem/cilastatin.
    Ariano RE; Kassum DA; Meatherall RC; Patrick WD
    Ann Pharmacother; 1992 Sep; 26(9):1075-7. PubMed ID: 1421667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of milrinone lactate in the presence of 29 critical care drugs and 4 i.v. solutions.
    Akkerman SR; Zhang H; Mullins RE; Yaughn K
    Am J Health Syst Pharm; 1999 Jan; 56(1):63-8. PubMed ID: 10048881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
    Johnson CE; Jacobson PA; Pillen HA; Woycik CL
    Am J Hosp Pharm; 1993 Apr; 50(4):703-6. PubMed ID: 8470689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Simmons M
    J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.